11.07.25 -- Powering Standards With Code: The Role Of Open Source In CDISC 360i

The Regional Site Manager (RSM) monitoring model eliminates numerous clinical trial risks by leveraging efficient, start-to-finish site management by a single, expert point of contact.

Clinical trials often fail due to poor feasibility planning. A new AI-powered approach bridges protocol design with real-world patient access to improve enrollment success.

Explore challenges QA professionals face in document reviews and expert strategies to boost accuracy, streamline workflows, and ensure compliance with evolving regulatory standards.

Learn how sponsors and CROs are using agentic AI to eliminate the unproductive time caused by manual, sequential processes and fragmented data systems.

Yochi Slonim, cofounder and CEO of Anima Biotech, explores how AI is evolving from generating ideas that anyone can access to building disease models that leverage proprietary data.

AI has great potential to enhance the efforts of your team members by accelerating data interactions. Watch this webinar and discover how AI can improve clinical trial outcomes and data management.

To better accommodate growing clinical data volume and decentralized trials, many organizations are activating AI-enabled trial tools to enhance workflows and ensure real time data review.

Hidden non-printable characters often compromise study data integrity. Automated SAS and R tools ensure your datasets are clean, reproducible, and ready for regulatory submission, saving crucial time.

As clinical research evolves, RWD and RWE play a crucial role in complementing conventional randomized controlled trials (RCTs) by capturing insights that accurately reflect clinical practice.

Built on interoperability, intelligence, and regulatory rigor, Castor Catalyst provides the infrastructure to connect, the automation to scale, and the expertise to turn complex data into actionable evidence.

Clinical trial portals should reduce friction—not add it. Streamlined tools empower sites, support patients, and give sponsors visibility without micromanagement or unnecessary complexity.